1-9 of 9
Massimo Santoro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases

Gennaro Chiappetta, Giovanni Tallini, Maria Cristina De Biasio, Francesca Pentimalli, Filomena de Nigris, Simona Losito, Monica Fedele, Sabrina Battista, Pasquale Verde, Massimo Santoro, Alfredo Fusco
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2675.
https://doi.org/10.1158/1078-0432.CCR-19-0487
Published: 15 April 2019
View article titled, Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases
Open the PDF for Retraction: FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases in another window
Journal Articles

Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases

Anna Tamburrino, Alfredo A. Molinolo, Paolo Salerno, Rebecca D. Chernock, Mark Raffeld, Liqiang Xi, J. Silvio Gutkind, Jeffrey F. Moley, Samuel A. Wells, Jr., Massimo Santoro
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (13): 3532–3540.
https://doi.org/10.1158/1078-0432.CCR-11-2700
Published: 01 July 2012
View article titled, Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases
Open the PDF for Activation of the mTOR Pathway in Primary Medullary Thyroid Carcinoma and Lymph Node Metastases in another window
Includes: Supplementary data
Journal Articles

Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells

Erika Martinelli, Teresa Troiani, Floriana Morgillo, Gabriella Rodolico, Donata Vitagliano, Maria Pia Morelli, Concetta Tuccillo, Loredana Vecchione, Anna Capasso, Michele Orditura, Ferdinando De Vita, S. Gail Eckhardt, Massimo Santoro, Liberato Berrino, Fortunato Ciardiello
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (20): 4990–5001.
https://doi.org/10.1158/1078-0432.CCR-10-0923
Published: 13 October 2010
View article titled, Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells
Open the PDF for Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells in another window
Journal Articles

Targeting the RET Pathway in Thyroid Cancer

Samuel A. Wells, Jr., Massimo Santoro
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (23): 7119–7123.
https://doi.org/10.1158/1078-0432.CCR-08-2742
Published: 30 November 2009
View article titled, Targeting the <em>RET</em> Pathway in Thyroid Cancer
Open the PDF for Targeting the <em>RET</em> Pathway in Thyroid Cancer in another window
Journal Articles

Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants

Teresa Guida, Suresh Anaganti, Livia Provitera, Richard Gedrich, Elizabeth Sullivan, Scott M. Wilhelm, Massimo Santoro, Francesca Carlomagno
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3363–3369.
https://doi.org/10.1158/1078-0432.CCR-06-2667
Published: 01 June 2007
View article titled, Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants
Open the PDF for Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants in another window
Journal Articles

BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma

Giuliana Salvatore, Valentina De Falco, Paolo Salerno, Tito Claudio Nappi, Stefano Pepe, Giancarlo Troncone, Francesca Carlomagno, Rosa Marina Melillo, Scott M. Wilhelm, Massimo Santoro
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1623–1629.
https://doi.org/10.1158/1078-0432.CCR-05-2378
Published: 06 March 2006
View article titled, BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma
Open the PDF for BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma in another window
Journal Articles

Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal Squamous Cell Carcinomas and Enhances Carcinoma Cell Proliferation and Invasiveness

Angela Celetti, Domenico Testa, Stefania Staibano, Francesco Merolla, Valentina Guarino, Maria Domenica Castellone, Renata Iovine, Gelsomina Mansueto, Pasquale Somma, Gaetano De Rosa, Vieri Galli, Rosa Marina Melillo, Massimo Santoro
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (22): 8019–8027.
https://doi.org/10.1158/1078-0432.CCR-05-0641
Published: 18 November 2005
View article titled, Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal Squamous Cell Carcinomas and Enhances Carcinoma Cell Proliferation and Invasiveness
Open the PDF for Overexpression of the Cytokine Osteopontin Identifies Aggressive Laryngeal Squamous Cell Carcinomas and Enhances Carcinoma Cell Proliferation and Invasiveness in another window
Journal Articles

Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer

Valentina Donati, Laura Boldrini, Matteo Dell'Omodarme, Maria C. Prati, Pinuccia Faviana, Tiziano Camacci, Marco Lucchi, Alfredo Mussi, Massimo Santoro, Fulvio Basolo, Gabriella Fontanini
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6459–6465.
https://doi.org/10.1158/1078-0432.CCR-05-0541
Published: 15 September 2005
View article titled, Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer
Open the PDF for Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung Cancer in another window
Journal Articles

FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases

Gennaro Chiappetta, Giovanni Tallini, Maria Cristina De Biasio, Francesca Pentimalli, Filomena de Nigris, Simona Losito, Monica Fedele, Sabrina Battista, Pasquale Verde, Massimo Santoro, Alfredo Fusco
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (11): 4300–4306.
Published: 01 November 2000
View article titled, FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases
Open the PDF for FRA-1 Expression in Hyperplastic and Neoplastic Thyroid Diseases in another window